United States Pharmaceuticals

Adial Pharmaceuticals Inc (ADIL)

Track

Over the past 90 days, Adial Pharmaceuticals Inc. has seen five insider buy transactions totaling $106,328.62, all executed by Coastlands Capital LP. These purchases occurred following the company's May 2026 earnings report, which showed an EPS beat. The stock has experienced a 108.7% price increase over the last three months.
Ticker: ADIL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Adial Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 16 Jul 2026
Value US$4,513,799.27 | Price 126.46 | Shares 20,660 (+11.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-16 B Purchase
Coastlands Capital LP
Large shareholder
20,660 +11.0%
126.46
US$4,513,799 		20,660 +11.0% 126.46 US$4,513,799
2026-07-16 2026-07-14 B Purchase
Coastlands Capital LP
Large shareholder
99,605 -48.0%
40.22
US$1,149,939 		99,605 -48.0% 40.22 US$1,149,939
2026-07-13 2026-07-10 B Purchase
Coastlands Capital LP
Large shareholder
91,808 -49.6%
284.80
US$2,824,563 		91,808 -49.6% 284.80 US$2,824,563
2026-07-13 2026-07-09 B Purchase
Coastlands Capital LP
Large shareholder
10,053 +2.7%
2.79
US$28,048 		10,053 +2.7% 2.79 US$28,048
2026-07-01 2026-06-29 B Purchase
Coastlands Capital LP
Large shareholder
25,000 +7.2%
2.60
US$65,000 		25,000 +7.2% 2.60 US$65,000
2023-10-03 2023-09-29 B Purchase
2.2
Schuyler Kevin
Non-Executive Director
700 +inf%
2.74
US$1,918 		700 +inf% 2.74 US$1,918
2022-01-03 2021-12-30 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +40.6%
2.71
US$27,100 		10,000 +40.6% 2.71 US$27,100
2022-01-03 2021-12-30 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
5,000 +11.1%
2.72
US$13,600 		5,000 +11.1% 2.72 US$13,600
2022-01-03 2021-12-30 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +100.0%
2.66
US$26,600 		10,000 +100.0% 2.66 US$26,600
2021-12-01 2021-11-30 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
10,600 +1.1%
2.75
US$29,179 		10,600 +1.1% 2.75 US$29,179
2021-12-01 2021-11-29 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
10,000 +1.1%
2.59
US$25,892 		10,000 +1.1% 2.59 US$25,892
2021-11-30 2021-11-26 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +40.9%
2.85
US$28,500 		10,000 +40.9% 2.85 US$28,500
2021-10-06 2021-10-04 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
200,000
0.00
US$0 		200,000 0.00 US$0
2021-04-08 2021-04-06 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
150,000 -21.5%
2.50
US$375,000 		150,000 -21.5% 2.50 US$375,000
2020-08-24 2020-08-20 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
350,000 -99.7%
1.21
US$423,500 		350,000 -99.7% 1.21 US$423,500
2020-03-30 2020-03-27 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
4,644 +46.4%
1.35
US$6,269 		4,644 +46.4% 1.35 US$6,269
2020-03-30 2020-03-27 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
10,000 +304.1%
1.34
US$13,400 		10,000 +304.1% 1.34 US$13,400
2020-03-30 2020-03-27 B Purchase
1.7
Newman James W. Jr.
Non-Executive Director
5,000 +50.0%
1.42
US$7,100 		5,000 +50.0% 1.42 US$7,100
2020-03-27 2020-03-26 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
12,652 +1.8%
1.47
US$18,598 		12,652 +1.8% 1.47 US$18,598
2020-03-27 2020-03-25 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
12,348 +1.8%
1.13
US$13,953 		12,348 +1.8% 1.13 US$13,953
2019-12-13 2019-12-12 S Sale Johnson Bankole A.

Chief Medical Officer

Officer Large shareholder
150,000 -17.7%
1.00
US$150,000 		150,000 -17.7% 1.00 US$150,000
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
600 +0.2%
3.30
US$1,978 		600 +0.2% 3.30 US$1,978
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
2,500 +0.7%
3.47
US$8,669 		2,500 +0.7% 3.47 US$8,669
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
30,000 +9.5%
3.47
US$104,154 		30,000 +9.5% 3.47 US$104,154
2019-04-01 2019-03-28 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
40,000 +14.6%
3.15
US$125,808 		40,000 +14.6% 3.15 US$125,808
2018-08-02 2018-07-31 B Purchase Goodman Tony Non-Executive Director
7,000
0.00
US$0 		7,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Johnson Bankole A. Non-Executive Director Large shareholder
1,400
0.00
US$0 		1,400 0.00 US$0
2018-08-02 2018-07-31 B Purchase Newman James W. Jr. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Newman James W. Jr. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
80,000
0.00
US$0 		80,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Gilliland Robertson H. Non-Executive Director
14,000
0.00
US$0 		14,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Schuyler Kevin Non-Executive Director
90,000
0.00
US$0 		90,000 0.00 US$0
Explore more

More insider trading research around Adial Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America